Questions About Larotrectinib: Who Should Be Tested, How Long Should They Be Treated, What Agent To Use
Douglas S. Hawkins MD Of The University of Washington School of Medicine Discusses Questions About Larotrectinib: Who Should Be Tested, How Long Should They Be Treated, What Agent To Use<br /><br /><br /><br />BACKRO...
Author: Annual-Meeting
Added: 06/03/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | University of Washington